Document is current
Any future updates will be listed below
-
Authors
Thatiparthi, Akshitha
Martin, Amylee
Liu, Jeffrey
Egeberg, Alexander
Wu, Jashin J. https://orcid.org/0000-0002-1722-1892
- License Information
-
More Information
Article History
Accepted: 27 March 2021
First Online: 16 April 2021
Declarations
:
: No sources of funding were used to conduct this study or prepare this manuscript.
: Ms. Thatiparthi, Mr. Liu, and Ms. Martin have no conflicts of interest that are directly relevant to the content of this article. Dr. Wu is or has been an investigator, consultant, or speaker for AbbVie, Almirall, Amgen, Arcutis, Aristea Therapeutics, Boehringer Ingelheim, Bristol-Myers Squibb, Dermavant, Dr. Reddy's Laboratories, Eli Lilly, Galderma, Janssen, LEO Pharma, Mindera, Novartis, Regeneron, Sanofi Genzyme, Solius, Sun Pharmaceutical, UCB, Valeant Pharmaceuticals North America LLC, and Zerigo Health. Dr. Egeberg has received research funding from Pfizer and Eli Lilly and honoraria for work as a consultant and/or speaker from Pfizer, Eli Lilly, Novartis, Galderma, and Janssen Pharmaceuticals.
: Not applicable.
: Not applicable.
: Not applicable.
: Data obtained from public domain resources.
: Not applicable.
: Initial concept by JJW and AT. AT, AM, and JL characterized and wrote the manuscript with oversight by AE and JJW. All authors discussed the results, read, and approved the final manuscript.
